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Abstract
Leptospirosis is a potentially fatal zoonotic disease in humans and animals caused by pathogenic spirochetes, such as
Leptospira interrogans. The mode of transmission is commonly limited to the exposure of mucous membrane or damaged
skin to water contaminated by leptospires shed in the urine of carriers, such as rats. Infection occurs during seasonal
flooding of impoverished tropical urban habitats with large rat populations, but also during recreational activity in open
water, suggesting it is very efficient. LigA and LigB are surface localized proteins in pathogenic Leptospira strains with
properties that could facilitate the infection of damaged skin. Their expression is rapidly induced by the increase in
osmolarity encountered by leptospires upon transition from water to host. In addition, the immunoglobulin-like repeats of
the Lig proteins bind proteins that mediate attachment to host tissue, such as fibronectin, fibrinogen, collagens, laminin,
and elastin, some of which are important in cutaneous wound healing and repair. Hemostasis is critical in a fresh injury,
where fibrinogen from damaged vasculature mediates coagulation. We show that fibrinogen binding by recombinant LigB
inhibits fibrin formation, which could aid leptospiral entry into the circulation, dissemination, and further infection by
impairing healing. LigB also binds fibroblast fibronectin and type III collagen, two proteins prevalent in wound repair, thus
potentially enhancing leptospiral adhesion to skin openings. LigA or LigB expression by transformation of a nonpathogenic
saprophyte, L. biflexa, enhances bacterial adhesion to fibrinogen. Our results suggest that by binding homeostatic proteins
found in cutaneous wounds, LigB could facilitate leptospirosis transmission. Both fibronectin and fibrinogen binding have
been mapped to an overlapping domain in LigB comprising repeats 9–11, with repeat 11 possibly enhancing binding by a
conformational effect. Leptospirosis patient antibodies react with the LigB domain, suggesting applications in diagnosis and
vaccines that are currently limited by the strain-specific leptospiral lipopolysaccharide coats.
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Introduction
Leptospirosis is a potentially fatal zoonotic disease in humans
and animals caused by pathogenic spirochetes, such as Leptospira
interrogans [1,2,3]. The mode of transmission is contact with
environmental water contaminated by leptospires shed in the urine
of carriers, such as rats. Leptospirosis is normally neither
communicable in humans nor transmitted by animal bite, and
the route of infection is commonly limited to damaged skin or
exposed mucous membrane. Thus, the wide range of its
occurrence from exposure during seasonal flooding of impover-
ished tropical urban habitats with large rat populations to
recreational activity in open water attests to the efficiency of
leptospiral infection [4,5,6,7]. The initial attempts to attach to a
skin injury and disseminate into the host occur as the pathogen
encounters the wound healing process as well as immune responses
of the host. Fibronectin and fibrinogen are major homeostatic
proteins involved in the critical process of hemostasis in a fresh
wound and in subsequent tissue repair [8,9,10,11]. In addition,
fibroblasts that newly populate an injury deposit cellular
fibronectin and collagen type III to rebuild extracellular matrix
[8,9,10,11,12,13]. Fibronectin and fibrinogen are also major
constituents in the circulation where they could potentially interact
with the leptospires in their hematogenous dissemination to distal
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deposited in extracellular matrix or become associated with host
cells. We previously showed that both host proteins are indeed
ligands for LigA and LigB, two outer membrane proteins in
pathogenic Leptospira strains that are members of a superfamily of
bacterial proteins containing immunoglobulin-like repeats with
adhesive properties [14,15]. LigA and LigB with 13 and 12
immunoglobulin-like repeats, respectively, are highly and rapidly
inducible in pathogenic Leptopira interrogans grown under conditions
mimicking the physiological osmolarity of bodily fluids [15,16,17].
Moreover, the osmotic induction of Lig enhances binding to
fibronectin and fibrinogen along with other host proteins in an in
vitro model of leptospiral adhesion to extracellular matrix [15].
Recombinant LigB has higher affinity than LigA for host proteins
[15], and the current study focuses on the potential role of the
former during cutaneous infection early in leptospirosis.
We now show that LigB binds fibroblast-derived fibronectin
with high avidity along with collagen type III, which is consistent
with leptospiral attachment to a wound being mediated by LigB.
In order to further demonstrate the importance of Lig as a
leptospiral adhesin, we show that the genetic transformation of
nonpathogenic L. biflexa with ligA or ligB from L. interrogans
increases the adherence of the surrogate to immobilized
fibronectin (manuscript submitted by C. P. Figueira, J. Croda,
H. A. Choy, et al.) and fibrinogen. Studies by others have shown
that LigB binds elastin, too [18], which is abundant in skin and
accessible in damaged vasculature. In addition to being an
adhesin, LigB disrupts the thrombin-mediated clotting cascade,
suggesting that Lig-fibrinogen binding could affect hemostasis and
possibly impair wound healing, thereby permitting leptospiral
entry into the circulation, dissemination, as well as further
infection. Taken together, the results showing LigB binding to
homeostatic proteins prevalent in wounds and also inhibiting fibrin
formation suggest that LigB could facilitate leptospiral transmis-
sion and dissemination. Given the multifunctional activities that
have potentially important impacts on the pathogenesis of
leptospirosis, it is of interest to further characterize the structure-
function properties of LigB in support of future biochemical
studies and the improvement of diagnostics and vaccines that are
currently limited by the strain-specific lipopolysaccharide coat of
the leptospires [1,2,3]. Thus, we have identified the repeat
domains in LigB that are important for binding to fibronectin
and fibrinogen. In addition, we show that leptospirosis patients
make antibodies for the binding domains in LigB.
Materials and Methods
Assurance of ethical use of human samples
This study was conducted according to the principles expressed
in the Declaration of Helsinki. Informed written consent was
obtained from participants and the study was approved by the
Institutional Review Board of the Research and Development
Committee, VA Greater Los Angeles Healthcare System (PCC #
2008-121778).
Recombinant proteins
The ligB gene from Leptospira interrogans serovar Copenhageni
strain Fiocruz L1-130 was subcloned to produce proteins
comprising ordered deletions of the LigB-specific immunoglobu-
lin-like repeats (Table 1). The nomenclature for the recombinant
Lig proteins is also indicated in Table 1. The cloning procedures
have been described [15], with the addition of the PCR primers
for the new proteins made available as a supplement here (Table
S1). Repeat 11 in LigB9-11 was replaced with repeat 8 or repeat
12 by DNA polymerase-mediated amplification of the fragment
for repeats 9 to 10 with the forward primer for repeat 9 and a
phosphorylated reverse primer for repeat 10 lacking an Xho I site
and any leader sequence (Table S1). The Nde I-digested DNA was
then blunt-end ligated to the Xho I-digested DNA fragment for
repeat 8 or repeat 12 that was amplified with the respective
phosphorylated forward primer lacking an Nde I leader sequence
and the respective reverse primer containing an Xho I site (Table
S1). The ligation product was cloned into pET-20b(+) (Novagen,
San Diego, CA). The LigB protein cloned from L. interrogans
serovar Pomona strain LC82-25 is also described in Table S1.
The expression of soluble recombinant protein in Escherichia coli
BLR(DE3)pLysS (Novagen) with isopropyl-b-D-thiogalactopyra-
noside induction at 30uC and purification with nickel-affinity
chromatography have been described [15]. Proteins were stored
sterile at 4uC to avoid denaturation from freeze-thawing and were
inspected for insoluble material and breakdown.
Fibrin formation
Fibrin formation from purified fibrinogen was examined
following a 30-min preincubation at room temperature in
100 mLo f3mM human fibrinogen (HYPHEN BioMed, Mason,
OH) with 5 mM LigB9-11 or SdrG, a fibrinogen-binding protein
from Staphylococcus epidermidis (generous donation from Dr. Magnus
Ho ¨o ¨k; [19]) in phosphate-buffered saline (PBS), pH 7.2. Clotting
was initiated with 0.1 U/mL human thrombin (HYPHEN
BioMed) and monitored by absorbance at 600 nm every minute
for 15 min; the increase in optical density corresponded with
Table 1. Recombinant LigB proteins.
protein
a amino acid coordinates
b mol. wt.
c
LigB79-12 A631-A1125 52,310
LigB8-12 Q673-A1125 48,170
LigB9-12 L760-A1125 39,329
LigB10-12 K851-A1125 29,581
LigB11-12 T942-A1125 20,173
LigB79-9 A631-L850 23,942
LigB79-10 A631-A941 33,350
LigB79-11 A631-A1031 42,777
LigB9-10 L760-A941 20,370
LigB9-11
d L760-A1031 29,796
LigB9-119 L760-S985 28,489
LigB99-11 S803-A1031 28,432
LigB9-10-8 L760-A941 + Q673-A759 29,210
LigB9-10-12 L760-A941 + T1032-A1125 29,902
LigB10-11 K851-A1031 20,048
aThe unique repeats of LigB from Leptospira interrogans Copenhageni L1-130
were subcloned in pET-20b(+)a tt h eNde I/Xho I site, which adds an initiating
methionine and an LEH6 tail to the Lig protein. The recombinant proteins are
named for their repeats; the prime designation indicates a partial repeat.
bLigB-unique repeats are residues 582 to 1118 (full repeat 7 to repeat 12). The
specific repeats are 7: K582-V669, 79: A631-V669, 8: Q673-V756, 9: L760-I845,
10: K851-F936, 11: T942-V1028, and 12: T1032-V1118. All constructs include
the short 3- to 5-residue linker following the last repeat, except repeat 12,
which includes seven residues into the LigB C-terminal domain (amino acids
1119 to 1890).
cincludes pET-encoded amino acids.
dalso cloned with N-terminal H6 in pET-14b at the Nde I/XhoI site, producing a
protein with mol. wt. 33,174.
doi:10.1371/journal.pone.0016879.t001
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(BSA) were tested with no effect on fibrin formation.
Host-protein binding by LigB proteins
LigB protein binding purified host proteins was measured with
an enzyme-linked immunosorbent assay (ELISA) as previously
described [15]. Purified human fibronectin from plasma (Sigma-
Aldrich, St. Louis, MO) or fibroblasts (Calbiochem, San Diego,
CA), the 35-kDa N-terminal domain, the 45-kDa gelatin-binding
domain, and the 70-kDa N-terminal fragment of fibronectin (all
from Sigma-Aldrich), fibrinogen (HYPHEN BioMed), fibrinogen
fragment D (HYPHEN BioMed), and collagen type III (Sigma-
Aldrich) were each immobilized in microtiter wells by overnight
incubation of 1 mg in 100 mL PBS, pH 7.2, at 4uC. Non-specific
binding sites were blocked with 20 mg/mL BSA in PBS, pH 7.2,
before incubation with recombinant LigB in 20 mg/mL BSA for
1 h at 37uC. After washing with PBS, bound LigB was located
with a monoclonal antibody for its polyhistidine tag (Novagen) and
measured by the absorbance at 450 nm of the enzymatic
conversion of 3,39,5,59-tetramethylbenzidine (TMB; Thermo
Scientific, Rockford, IL) by horseradish peroxidase coupled to a
goat antibody for murine IgG (Novagen). Binding affinities were
estimated with the apparent Kd derived from the LigB
concentration at half-maximal binding. The mean Kd values
and standard deviations were calculated from multiple indepen-
dent experiments and compared by one-way ANOVA. The results
are presented as composite curves showing the mean and standard
deviation of each point compiled from multiple experiments as
indicated; where n is at least 10, the standard error is shown.
Transformation of Leptospira biflexa
Saprophytic L. biflexa serovar Patoc strain Patoc 1, which lacks
the lig genes, was used as a non-pathogenic surrogate to express
ligA or ligB from pathogenic L. interrogans serovar Copenhageni
strain Fiocruz L1-130 (manuscript submitted by Figueira et al.).
Briefly, L. biflexa was transformed by electroporation with either
the pSLe94 cloning vector carrying the spectinomycin-resistance
gene or pSLe94 with ligA or ligB from L. interrogans inserted at the
Pvu II site for constitutive expression under the control of the
borrelial flgB promoter. The transformants were amplified in
liquid Ellinghausen-McCullough-Johnson-Harris (EMJH) medium
and plated onto EMJH agar with 40 mg/mL spectinomycin at
30uC. Isolated colonies were verified for the presence of the lig
genes by PCR and maintained in serial passage in EMJH under
selection.
For the adhesion assays, the transformed leptospires were grown
in EMJH medium at 30uC under spectinomycin selection to late-
log phase, when surface expression of the Lig proteins has been
verified (Figueira et al.) and the Lig content confirmed in the
present study by immunoblotting with a rabbit polyclonal
antibody recognizing both LigA and LigB (Figure S1). Cellular
binding to fibrinogen and fibrinogen fragment D was measured
with an ELISA ([15], Figueira et al.). Briefly, microtiter wells
coated with 1 mg purified human fibrinogen or fibrinogen
fragment D (both from HYPHEN BioMed) and blocked with
20 mg/mL BSA were incubated with 3610
8 leptospires at 30uC
for 1 h. Non-adherent cells were removed with washes in PBS with
5 mM MgCl2 and the adherent cells were fixed with 4% (w/v)
formaldehyde and detected by probing with a rabbit polyclonal
antibody for wild-type L. biflexa (MyBioSource, San Diego, CA),
followed by measuring the activity of horseradish peroxidase
coupled to an antibody for rabbit IgG (GE Life Sciences,
Piscatawny, NJ). The average increase and standard deviation in
adhesion by the lig transformants from at least three separate
experiments are reported. In individual experiments, the mean
level of adhesion and standard deviation from triplicate wells of
each transformant were compared to wild-type cells by ANOVA
with the Dunnett post test.
Reactivity of leptospirosis patient antibodies with Lig
proteins
Antisera were collected from laboratory-confirmed leptospirosis
patients in Salvador, Brazil, during acute infection and convales-
cence [4]. Immunoglobulin G was prepared from pooled and
individual samples with Melon G resin (Thermo Scientific) and
checked for purity with denaturing polyacrylamide gel electro-
phoresis and Coomassie Blue staining. Protein concentrations
were determined with the bicinchoninic assay. The antibodies
were titrated with an ELISA against recombinant LigB79-12,
LigB9-11, and S. epidermidis SdrG, which were immobilized in
microtiter wells by overnight incubation of 100 mL of 0.5 mM
protein in PBS, pH 7.2, at 4uC. Empty space was blocked with
Protein-Free Blocking Buffer (Thermo Scientific) and the bacterial
proteins probed with patient antibodies in 100 mL 20 mg/mL
BSA in PBS, pH 7.2, at room temperature for 1 h. The PBS-
washed, binding antibodies were detected with a goat antibody for
human IgG conjugated to horseradish peroxidase (Sigma-Aldrich)
and measured by absorbance at 450 nm of the enzymatic
conversion of TMB (Thermo Scientific).
Results
LigB-fibrinogen binding inhibits fibrin formation
Leptospires gaining entry in abraded or cut skin encounter an
environment of increased osmolarity replete with compounds
involved in wound healing and tissue repair. The osmotic change
induces the expression of the Lig adhesins, which can promote the
binding of the spirochetes to host proteins, such as fibronectin and
fibrinogen [15], two major plasma proteins that could be lost from
surrounding damaged vasculature. In freshly injured skin,
hemostasis is a critical process involving clot formation from
fibrinogen. In addition to enhancing leptospiral adhesion to
fibrinogen in a wound (see cellular model below), LigB could
modulate clotting. Its binding of fibrinogen partially inhibited
thrombin-catalyzed fibrin formation, suggesting a role in counter-
ing the effects of coagulation that could impede the dissemination
of leptospires from an entry site in damaged skin. In three separate
determinations, LigB9-11, a recombinant LigB protein with full
fibrinogen-binding activity (see below), decreased fibrin formation
with purified fibrinogen by 22 to 43% (mean and standard
deviation, 29612%). A representative assay is shown in Figure 1
along with the nearly complete suppression of clotting obtained
with the Staphylococcus epidermidis adhesin, SdrG [19], which has
two- to threefold higher avidity for fibrinogen (data not shown).
Note that the significant delay in clotting caused by LigB-
fibrinogen binding could also provide time for the spirochetes to
enter the bloodstream and disseminate to distal tissue.
LigB binds host proteins associated with wound healing
The osmotic induction of the Lig adhesins could also enhance
the attachment of the pathogen to exposed extracellular matrix
containing fibronectin, collagen, laminin, and elastin, as well as
to plasma proteins lost from damaged blood vessels, such as
fibronectin and fibrinogen [15,18]. Both the cellular isoform of
fibronectin and collagen type III are synthesized by fibroblasts
in damaged tissue, and L. interrogans has been shown to adhere to
fibronectin made by cultured fibroblasts [20]. We have shown
that LigB79-12 (previously named LigB U1), a recombinant
LigB Binds Homeostatic Wound-Healing Proteins
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like repeats, binds plasma fibronectin and mediates leptospiral
adhesion [15]. Here a smaller LigB protein, LigB9-11, found to
retain fibronectin-binding activity with just three repeats (see
below), is shown to also bind fibroblast fibronectin with similar
high avidity, exhibiting apparent Kdso f3 2 615 nM (17
independent determinations) and 25610 nM (n=3) for plasma
and cellular fibronectin, respectively (representative experiments
shown in Figure 2A). LigB9-11 also showed high-affinity
binding to collagen type III with an estimated Kd of 30 nM
(range 10 nM for two determinations) (Figure 2B). Moreover,
the interaction observed for LigB9-11 with type III collagen
proved to be stronger than the previously measured non-
saturating activities of LigB79- 1 2w i t hc o l l a g e nt y p e sIa n dI V
[15], suggesting a significant role for type III collagen binding
early during infection in adhering to tissue undergoing wound
healing and repair.
Transformation with ligA and ligB enhances adhesion of
nonpathogenic L. biflexa
The osmotic induction of Lig expression in pathogenic L.
interrogans enhances spirochetal binding to immobilized fibronectin
and fibrinogen in an in vitro model for attachment to host tissue
[15]. In a direct demonstration of the role of Lig in adhesion, we
have recently shown that the constitutive expression of either LigA
or LigB directed by the borrelial flgB promoter, on the surface of
nonpathogenic L. biflexa transformed with ligA or ligB from
L. interrogans, enhances the adherence of the saprophyte to both
cellular and plasma fibronectin (Figueira et al.). In accord with the
high-avidity interactions observed for recombinant LigB protein
with cellular as well as plasma fibronectin (Figure 2A), the ligB
transformant of L. biflexa bound cellular and plasma fibronectin
twofold more than the parental wild-type strain (Figueira et al.). We
now show that genetic augmentation with either ligA or ligB also
promoted leptospiral adhesion to fibrinogen (Figure 3). The
adherence of the ligA transformant was elevated by 55614%
(seven independent determinations) compared to either the native
wild-type, nonpathogenic strain or these cells transformed with the
empty pSLe94 vector. The ligB transformant also bound to
immobilized fibrinogen 55612% (four determinations) more than
wild-type L. biflexa. In the representative experiment shown in
Figure 3, ligA transformation increased attachment by 56%
(P,0.01 compared to wild-type leptospires) and the insertion of
ligB led to 37% more binding (P,0.05). In addition, adhesion to
fragment D of fibrinogen (see below) increased by 58 and 73% for
the ligA and ligB transformants, respectively, over wild-type L.
biflexa (P,0.01; Figure 3).
Fibronectin-binding sequences in LigB
We previously showed that two separate regions in fibronectin,
the N-terminal and the adjoining gelatin-binding domains, are
recognized by recombinant Lig proteins comprising the variable
immunoglobulin-like repeats (C-terminal half of LigA, repeats 79 to
13, and the middle portion of LigB, repeats 79 to 12; the proteins
LigA U and LigB U1, respectively [15]). A collection of
recombinant terminal-deletion and other mutant LigB proteins
has now been used to identify the repeat domains within LigB79-12
that are required for the interactions with fibronectin (Table 1).
Repeat 7 was not needed for LigB binding to fibronectin or its
70-kDa N-terminal fragment, which consists of the contiguous
N-terminal and gelatin-binding domains (Figure 4A and data not
Figure 1. LigB binds fibrinogen and inhibits fibrin formation.
Thrombin-catalyzed clotting was measured spectrophotometrically
following a 30-min incubation of 3 mM human fibrinogen with PBS or
5 mM of either LigB9-11 or the Staphylococcus epidermidis fibrinogen-
binding adhesin, SdrG.
doi:10.1371/journal.pone.0016879.g001
Figure 2. LigB binds cellular fibronectin and collagen type III. A recombinant LigB protein was tested in an ELISA for binding to A) human
plasma and cellular fibronectin and B) human type III collagen.
doi:10.1371/journal.pone.0016879.g002
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repeat 7 in LigB8-12 maintained the same avidity observed for
LigB79-12, with apparent Kdso f2 6 63 nM (three separate
determinations) and 2368 nM (n=18), respectively (see Table 2
for comparative summary of binding avidities for the LigB proteins
tested in this study). In contrast, LigB repeat 9 was necessary for
binding fibronectin and its N-terminal fragment. Whereas
LigB10-12 and LigB10-11 were weak or inactive in binding, the
addition of repeat 9 to either protein reconstituted virtually full
activity with Kdso f2 2 63 nM (n=5) for LigB9-12 and
31614 nM (n=19) for LigB9-11 (Figure 4B). The N-terminal
portion of repeat 9 was crucial. Deletion of the N-terminal half of
repeat 9 in LigB9-11 caused complete inactivation (Table 1; data
not shown). Another modification that tacked on a hexahistidine
tag along with 15 vector-encoded residues to the amino terminus
of repeat 9 in LigB9-10 and LigB9-11 also ablated fibronectin
binding (Table 1; data not shown).
The two most carboxy-proximal immunoglobulin-like repeats in
LigB, 11 and 12, by themselves did not bind fibronectin or the 70-
kDa N-terminal fragment (Figure 4C, 4D, and data not shown).
Different preparations of purified LigB11-12 were tested and
found to be non-binding. In addition, of all LigB proteins tested,
only repeats 11 and 12 did not bind fibronectin. Moreover, the
addition of repeat 10 to the inactive repeats in LigB10-11 and
LigB10-12 supported only weak binding at best, suggesting that
repeats 11 and 12 did not harbor any cryptic binding activity
(Figure 4B). Although Lin et al. had located a fibronectin-binding
domain in this part of LigB from L. interrogans serovar Pomona
[21,22], we subcloned a LigB protein consisting of repeats 11 and
12 from a Pomona strain and found it to be inactive (Table S1;
data not shown).
As demonstrated above, repeat 9 was necessary for fibronectin
binding; however, it alone was not sufficient to account for the full
activity of LigB79-12. A nexus between repeats 9 and 10 was also
needed; dividing LigB79-12 between these two repeats produced
two low-activity half-molecules, LigB79-9 and LigB10-12
(Figure 4B). A second requirement for repeats 9 and 10 to fully
express their fibronectin-binding activity was the non-binding
repeat 11. For example, LigB79-10 displayed only moderate
activity with an estimated Kd of 77647 nM (n=7) (Figure 4C).
However, the addition of repeat 11 conferred full binding activity
as shown by LigB79-11 with Kd 27614 nM (n=4; significantly
stronger than LigB79-10, with P,0.01) (Figure 4C). The
requirement for repeat 11 was also evident in comparing the
moderate activity of LigB9-10 (Kd 252630 nM, n=5) to the tight
binding by LigB9-11 and LigB9-12, both being significantly
different from LigB9-10, with P,0.001 (Figure 4D). Thus, the
sequences involved in high-affinity interaction with fibronectin are
contained in LigB9-11. The enhancement mediated by repeat 11
appeared somewhat tolerant of sequence requirements. Although
deletion of the carboxyl half of repeat 11 diminished the activity of
LigB9-11 by 80%, as did replacing repeat 11 with repeat 8 or 12,
complete inactivation did not occur (Table 1; data not shown).
Note that in the absence of repeat 11, fibronectin binding was
somewhat dependent on repeats 79 and 8: LigB79-10 compared to
LigB9-10, with Kdso f7 7 647 nM and 252630 nM, respectively
(Table 2).
Fibrinogen-binding sequences in LigB
In addition to binding fibronectin (Figure 2A, 4), LigB79-12
and its fibronectin-binding region identified above in repeats 9 to
11 recognized fragment D, the globular portion of human
fibrinogen containing the C-terminal portions of the a-, b-, and
c-chains ([23]; Figure 5A, 5B). Equivalent results were obtained
with both whole fibrinogen and its fragment D. Binding by LigB9-
11, for example, gave statistically equivalent Kdso f2 8 614 nM
(n=4) with fibrinogen and 2666 nM (n=6) with fragment D;
results are thus reported for either protein interchangeably. The
repeats that are important for fibrinogen interaction have been
mapped to the fibronectin-binding region of LigB. Thus, repeat 9
was also necessary for fibrinogen binding as shown by the marked
enhancement in activity with its addition to the virtually inactive
LigB10-12 (Figure 5A). The apparent Kd of 37613 nM (n=3)
for LigB9-12 matched that for LigB79-12, 34611 nM (n=7) (see
Table 2 for a comparison of binding affinities for the LigB
proteins tested). As with fibronectin, repeats 11 and 12 by
themselves did not bind fibrinogen (Figure 5A). Thus, repeats 9
and 10 were also important for fibrinogen binding. Here an
association between the two repeats was also required; separating
them as in LigB79-9 and LigB10-12 significantly weakened the
activity observed with intact LigB79-12 (Figure 5B). LigB9-11
containing the two repeats and constituting the fibronectin-
binding region of LigB was also sufficient to support full
fibrinogen-binding activity, with a Kd of 2769 nM (n=10) being
statistically the same as that for LigB79-12 (Figure 5B). In
addition, the obligatory nexus between repeats 9 and 10 was
evident in the significant increases in the activities of LigB9-12 v.
LigB10-12 (Figure 5A) and LigB79-10 v. LigB79-9 (Figure 5C).
As with fibronectin binding, the N-terminal portion of repeat 9
was particularly sensitive to alterations. The addition of non-Lig
sequence, such as 15 vector-encoded residues plus a His tag, to its
amino terminus rendered LigB9-11 virtually inactive with less than
10% residual activity. Deletion of the amino half also eliminated
fibrinogen binding (Table 1; data not shown).
The non-binding repeat 11 also served as an enhancer in the
interaction with fibrinogen. Its addition to LigB79-10 (Figure 5C)
and LigB9-10 (Figure 5D), two proteins with moderate activity,
increased fibrinogen binding substantially by several fold
(Table 2). For example, LigB9-11 had sixfold higher affinity for
fibrinogen than LigB9-10: Kd 2769 nM (n=10) v. 169640 nM
Figure 3. lig transformation of Leptospira saprophyte enhances
adhesion to fibrinogen. Wild-type (wt) L. biflexa and cells
transformed with ligA or ligB from L. interrogans were tested for
binding to immobilized human fibrinogen or its fragment D in an ELISA.
Three x 10
8 leptospires were incubated for 1 h at 30uC and adherent
cells fixed with formaldehyde and detected with a rabbit antibody to
intact L. biflexa. A representative of multiple experiments is shown with
means and standard deviations of triplicates. Statistically significant
increases compared to binding by wt with each host protein were
determined by one-way ANOVA (@, *, P,0.01; #,P ,0.05).
doi:10.1371/journal.pone.0016879.g003
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activity obtained with LigB9-11, which was equivalent to the
activities of LigB9-12 and LigB79-12, clearly showed that repeat
11 alone was sufficient to enhance fibrinogen binding by LigB9-10
(Figure 5D). Removal of the carboxyl half of repeat 11 lowered
the activity of LigB9-11 by 50%, suggesting that the intact non-
binding repeat was necessary to support optimal fibrinogen
binding (Table 1; data not shown).
Host antibody responses to ligand-binding domain in
LigB
The LigB repeats involved in host-protein binding presumably
have some degree of exposure on the leptospiral surface for their
interaction with cognate ligands. In order to determine whether
this functional accessibility would also render the repeats vulnerable
to host immune responses, the antigenicities of the recombinant
LigB proteins were compared. Immunoglobulin G purified from
patient antisera collected during acute leptospirosis infection and
during convalescence recognized epitopes in LigB79-12 as well as in
LigB9-11 (Figure 6), reflecting the expression of LigB by the
infecting leptospires and perhaps its surface-available fibronectin/
fibrinogen-binding domain. The S. epidermidis fibrinogen-binding
protein, SdrG, was used as a negative control antigen without
reactivity (data not shown).
Discussion
LigB expression and binding profiles suggest an early
role in cutaneous infection
The risk of leptospirosis commonly occurs in impoverished
urban habitats where seasonal flood waters become contaminated
by rodent urine. However, flowing rivers and lake water
contaminated with presumably much lower concentrations of
leptospires than in urban floods also present significant risks.
Indeed, the infection of humans and animals in open water is
evidence of the effective mechanisms used by pathogenic Leptospira
spp. in the productive initial contact with hosts [5,6,7]. Whereas it
seems clear that damaged skin is infected during urban flooding or
Figure 4. LigB repeats in fibronectin binding. Recombinant LigB proteins comprising the indicated immunoglobulin-like repeats were tested in
an ELISA to identify the fibronectin-binding region. Composite binding curves with means and standard deviations (standard errors for LigB79-12 and
LigB9-11) from multiple assays depict their comparative binding avidities to demonstrate that A) repeat 7 is not necessary, B) repeat 9 is necessary
along with a nexus with repeat 10, and C, D) repeats 11 and 12 do not bind directly, but are involved in the interaction with fibronectin. See text and
Table 2 for the apparent Kds.
doi:10.1371/journal.pone.0016879.g004
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membrane is infected from exposure such as in water sports. The
externally exposed mucosa of the eye, nose, mouth, and
respiratory tract is a formidable barrier. Indeed, both dermis
and mucosa have complex immune systems [24,25]. In addition to
containing immune cells, such as dendritic cells, mucous
membranes secrete a protective layer of mucus that harbors
antibodies, primarily IgA [26,27,28]. In a previous study of the
guinea pig model of leptospirosis that compared different routes of
infection, the LD50 for subcutaneous injection was twofold higher
than with an intraperitoneal bolus, and conjunctival inoculation
was yet another three orders of magnitude higher than in
subcutaneous infection [29], attesting to the effectiveness of the
mucosal barrier. The results from the present study suggest that
there are specific mechanisms mediated by LigB that promote the
transmission of leptospirosis via damaged skin.
Healthy skin and its appendages, such as hair and fur, serve as
an effective barrier to pathogens. However, damaged skin provides
leptospires not only an opportunity for physical access into a host,
but also exposure to metabolic processes that are activated in a
wound. At the time of initial contact with the leptospires, the
injury will be at one of several stages of healing and repair. Some
of these processes may be conducive to the successful initiation of
infection by a pathogen. One of the very first to occur in a fresh
wound is hemostasis involving the plasma protein, fibrinogen, in
the damaged vasculature [8,9,10,11]. The subsequent repair
process includes fibroblasts recruited to the site that lay down a
temporary extracellular matrix containing mostly cellular fibro-
nectin and type III collagen [8,9,10,11,12,13]. Our results suggest
that invading leptospires could adapt to this environment. In
addition, the inflammatory responses that accompany tissue
damage likely have effects on leptospires that are yet to be
understood.
Furthermore, other mammalian stimuli to which pathogenic
leptospires respond include physiological osmolarity [16,17] and
temperature [30,31], which have been shown to rapidly induce the
expression of LigA and LigB, making these proteins potential
mediators of interactions with the host especially at the onset of an
infection. The transient induction of Lig expression by host body
temperature [30] and the unknown persistence of osmotic
induction suggest that the primary functions of the Lig proteins
are assigned to early infection. In addition, elastin binding has
been described for LigB [18], suggesting a function early in
cutaneous infection involving elastin-rich skin and damaged
vasculature. Thus, our hypothesis is that the Lig proteins,
especially LigB, which we previously showed to bind the human
plasma proteins, fibronectin and fibrinogen, with high avidity [15],
help to mediate successful infections in cutaneous wounds. In
support of this, we show that LigB binds fibrinogen and inhibits
fibrin formation (Figure 1), and that LigB binds fibroblast-derived
fibronectin and type III collagen with nanomolar avidity
(Figure 2).
The inhibitory effect of LigB on fibrin formation (Figure 1)
would occur during leptospiral contact with a fresh wound, since
fibrinogen-mediated hemostasis occurs at the onset of an injury.
However, the disruption of fibrin formation could adversely affect
processes beyond hemostasis that involve interactions with fibrin
and the fibronectin associated with it in a clot, such as wound
stabilization, platelet function, phagocytosis, tissue repair, and
angiogenesis [8,9,10,11,32,33]. Thus, their impairment could
conceivably promote the initiation of an infection and facilitate
further infection and dissemination. The moderate level of
inhibition by LigB compared to the complete prevention of
clotting by the S. epidermidis fibrinogen-binding protein, SdrG
(Figure 1; [19]), suggests that the primary function of LigB is in
adhesion. Another fibrinogen-binding protein, ClfA from S. aureus,
also disrupts fibrin formation [34]. It is of note that immunoglob-
ulin-like repeats in these three fibrinogen-binding proteins affect
clotting by interacting with different parts of fibrinogen. LigB
binds fragment D (specific chain unidentified), SdrG binds an N-
terminal site in the b-chain in fragment E [19], and ClfA binds a
C-terminal site in the c-chain in fragment D [35,36,37].
The plausibility of LigB having a role during early infection in
the skin raises the issue of the suitability of animal models of
leptospirosis that use experimental methods such as intraperitoneal
injection instead of natural routes of infection. It is possible that
the former might systematically preclude the detection of
mechanisms required for infection at a natural barrier or at low
dose. This would apply in the case of gene knock-out models that
seek to identify virulence factors, e.g., in the ligB knock-out study
that found no decrease in the infectivity of hamsters with the ligB-
null mutant compared to wild-type leptospires [38]. One
interpretation is functional redundancy for an important step
carried out by LigB. For example, LigA also binds host proteins
that LigB binds [15]. Alternatively, the experimental conditions,
such as the route and dosage of infection, may not have been
suitable to examine the requirements for low-dose, natural
infection, e.g., in contaminated river water.
Saprophyte transformation as a cellular model of
pathogenic function
Fibrinogen binding by LigB could serve several purposes in
establishing an infection in damaged skin. In addition to disrupting
hemostasis, LigB binding could mediate leptospiral adhesion to
tissue via fibrinogen lost from damaged vasculature and deposited
Table 2. Relative affinities of LigB proteins for fibronectin and
fibrinogen.
Fibronectin Fibrinogen
LigB Kd
a %
b Kd
a %
b Category
79-12 2368 100 34611 100 full binding
79-11 27614
c 100 see below -
8-12 2663 100 n.d. -
9-12 2263 100 37613 100
9-11 31614
d 100 2769
d 100
79-11 see above - 63 (28) 54 moderate/low
79-10 77647
c, e 30 207 (165) 16
9-10 252630
d, e 91 6 9 640
d 20
79-9 weak - weak - weak
10-12 weak - weak -
10-11 inactive - n.d. - inactive
11-12 inactive - inactive -
aApparent dissociation constant estimated by ELISA. Mean and standard
deviation from at least three separate experiments is shown, except where the
mean from two experiments is shown with the range in parentheses; n.d., not
determined.
bRelative affinity compared to LigB79-12; where 100% is shown, the affinities are
statistically equivalent.
cSignificant 2.9-fold enhancement by repeat 11 (P,0.01).
dSignificant 8.1-fold enhancement by repeat 11 for fibronectin binding
(P,0.001), and 6.3-fold stimulation for fibrinogen binding (P,0.001).
eSome dependence on repeats 79 and 8 in the absence of repeat 11, giving a
3.3-fold effect (P,0.001).
doi:10.1371/journal.pone.0016879.t002
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bloodstream through damaged vessels, followed by Lig binding to
circulating fibrinogen as a vehicle for dissemination to distal tissue.
Our results with purified recombinant LigB proteins support these
potential roles for Lig-mediated leptospiral attachment to
fibrinogen.
Moreover, by applying a novel cellular model created to test for
virulence factors, we have demonstrated the potential role of
cellular LigB (and LigA) in leptospiral adhesion (Figueira et al.). In
contrast to the Lig expression and resulting enhanced adhesion
observed with L. interrogans [15,16,17], osmotic induction is not
necessary for surrogate expression, which is constitutive and
significantly increases leptospiral binding to two homeostatic
proteins found in damaged skin, cellular fibronectin (Figueira et al.)
as well as fibrinogen (Figure 3).
LigB repeats 9 to 11 form the binding domain for
fibronectin and fibrinogen
The immunoglobulin-like repeats in LigB are involved in
binding elastin in addition to fibronectin and fibrinogen as well as
laminin and collagen types I, III, and IV ([15,18,21]; Figure 2B).
We have found the binding regions for both fibronectin and
fibrinogen in LigB to overlap within repeats 9 to 11, with repeats 9
and 10 binding directly and repeat 11 acting as an enhancer
(Table 2). With little variation, the same LigB proteins exhibit full
activity with similar avidity for both host proteins (Table 2). In the
moderate-affinity group, the LigB proteins contain the repeats 9/
10 interface, but lack repeat 11, with the exception of LigB79-11 in
fibrinogen binding being at the high end of this category. The
promotion of the proteins in the moderate-binding group to full
activity entails three- to eightfold enhancement by repeat 11 for
fibronectin binding and three- to sixfold stimulation in fibrinogen
binding (Table 2). Although we have not determined the
sequences required for collagen binding, LigB9-11 also binds type
III collagen (Figure 2B).
Immunoglobulin-like repeats in other bacterial adhesins are
organized in bipartite domains to bind different host proteins, such
as the N2 and N3 subdomains in ClfA and ClfB from S. aureus and
SdrG from S. epidermidis that bind fibrinogen, and the N1 and N2
subdomains in CNA from S. aureus that bind collagen
[37,39,40,41,42]. The S. aureus fibronectin-binding adhesin,
FnBPA, also binds fibrinogen and elastin [43]. Its N-terminal A
region has a three-dimensional structure similar to the fibrinogen-
binding N2-N3 domains in ClfA and SdrG; in FnBPA, the A
region binds both fibrinogen and elastin [43]. As discussed above,
the common domains in these adhesins bind different sites in
fibrinogen. Interestingly, although similar, ClfA binds the c-chain
and ClfB the a-chain [35,36,37,44]. Thus, the same or similar
Figure 5. LigB repeats in fibrinogen binding. Recombinant LigB proteins comprising the indicated immunoglobulin-like repeats were tested in
an ELISA to identify the fibrinogen-binding region. Composite binding curves with means and standard deviations (standard errors for LigB9-11, and
ranges for LigB79-10 and LigB79-11) from multiple experiments show that A) repeat 9 is necessary and the carboxy-proximal repeats, especially 11
and 12, do not bind by themselves, B) a repeats 9-10 nexus is necessary and B9-11 is sufficient for full activity, C) low- (10) and non-binding (11)
repeats enhance activity, and D) non-binding repeat 11 is needed for complete fibrinogen binding. See text and Table 2 for comparative Kds.
doi:10.1371/journal.pone.0016879.g005
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bacterial proteins can interact with heterogeneous host ligands. It
remains to be determined whether LigB binds fibrinogen and
other proteins with its immunoglobulin-like repeats in a mecha-
nism similar to those of the staphylococcal adhesins. However, it is
likely that the ability of leptospires to gain entry to a host is
substantially enhanced by the ability of the LigB immunoglobulin-
like repeats to bind multiple homeostatic proteins that are
abundant in damaged skin undergoing repair.
Although repeats 7 and 8 are not necessary for binding, they are
not inactive in binding (data not shown). In contrast, repeats 11
and 12 alone do not have any direct binding activity (Figure 4C,
4D, 5A; Table 2). However, in their native context with other
repeats, such as 9 and 10, they may acquire binding activity that
mediates the enhancement obtained with repeat 11. Given that the
immunoglobulin-like repeats are highly similar [45], it is possible
that the nature of their activity, whether it is binding directly to
fibronectin or fibrinogen or imparting conformational changes
that modulate binding, depends on their interaction with other
repeats. The evidence in support of interactions between LigB
repeats includes the requirements for the apposition of repeats 9
and 10 (Figure 4B, 5B; Table 2) and the inclusion of the
otherwise non-binding repeat 11 for LigB9-10 to express its full
binding activity (Figure 4D, 5D; Table 2). Both requirements
are reminescent of the mechanisms used by the staphylococcal
adhesins discussed above. The N2-N3 and N1-N2 domains first
bind fibrinogen and collagen, respectively, followed by the
interaction of adjoining downstream sequences with the binding
domains [37,41,42]. In LigB, the essential nexus of repeats 9 and
10 is evident in comparing the full fibronectin- and fibrinogen-
binding activities of LigB79-12 to the low activities of LigB79-9 and
LigB10-12 (Figure 4B, 5B; Table 2). It appears that the putative
bipartite binding domain can be formed by intermolecular
interaction; an equimolar mixture of LigB8-9 and LigB10-11,
each weakly binding, yielded fibronectin-binding activity similar to
LigB9-10 (data not shown). In contrast, a similar mixture of non-
binding LigB11-12 plus moderate-binding LigB9-10 did not lead
to an enhancement (data not shown), suggesting that repeat 11
modulates fibronectin binding by an intramolecular effect on the
conformation of LigB. The disruption of productive fibronectin
binding by the replacement of repeat 11 in LigB9-11 with either
repeat 8 or repeat 12 is possibly due to an adverse effect on the
active conformation of repeats 9 and 10. Indeed, the addition of a
non-Lig sequence, such as a 21-residue vector-encoded His-tag
cassette, to its amino terminus inactivated LigB9-11, possibly due
to the placement of a hydrophilic region that does not occur in the
naturally adjoining repeat 8 and that can perturb the interaction of
repeat 9 with repeats 10 and 11.
Other studies with LigB from L. interrogans serovar Pomona
found that LigBCen2, a recombinant protein comprising a partial
repeat 11, repeat 12, and a 47-amino acid extension into the non-
repeat C-terminal domain of LigB, could account for binding the
N-terminal domains of fibronectin [21,22]. The interaction with
the gelatin-binding domain of fibronectin showed micromolar
avidity with a Kd of 1.9 mM, although no binding was observed
with individual repeats 10 and 11 (repeat 12 not shown, [46]). In
general, the recombinant LigB proteins from serovar Pomona
showed lower micromolar avidity in fibronectin binding compared
to the nanomolar avidity reported here for the proteins from
serovar Copenhageni ([46]; Table 2). Given our finding of the
disruptive effect of inserting non-Lig sequence to the amino
terminus of LigB9-11, some of the differences between the results
with LigB from L. interrogans serovar Copenhageni and those
reported for serovar Pomona may be due to the addition of non-
Lig N-terminal sequences to the latter protein, which included
either the glutathione-S-transferase protein or a His tag [46].
Nevertheless, there is some general agreement, such as the weak or
absent binding activity of repeats 10 to 12. Moreover, LigB from
both serovars exhibits the enhancement in fibronectin binding by
C-proximal non-binding repeats. The 30-fold increase by repeat
12 in the Pomona protein appears to be mediated by a
conformational change that possibly involves inter-repeat interac-
tion [46]. In the Copenhageni protein, repeat 11 stimulates
fibronectin binding three- to eightfold (Table 2). There is also a
similar enhancement (three- to sixfold) for fibrinogen binding by
LigB from Copenhageni (Table 2). Interestingly, LigA did not
inherit repeats 11 and 12 from its ancestor, LigB [45], and shows
weaker binding activity compared to LigB [15].
Taken together, the results indicate that there are multiple
binding sites in LigB for fibronectin and fibrinogen, which may
present more options in designing new diagnostics and therapeu-
tics for leptospirosis. The activity of immunoglobulin-like repeats
in bacterial proteins is not restricted to the binding of extracellular
host proteins, but also includes the interaction with receptors on
host cells, such as b1 integrins for invasin of pathogenic Yersinia
spp. and Tir for intimin of pathogenic Escherichia coli [47,48].
Furthermore, although they are not considered to be immuno-
globulin-like repeats, the eleven tandem repeats in FnBPA from
S. aureus that are downstream of the fibrinogen- and elastin-
binding A region individually bind fibronectin with varying
affinities [49]. Thus, it is clear that bacterial pathogens have
adopted variations on the successful theme of using tandem
repeats of structures such as the immunoglobulin fold to interact
with host proteins, thereby promoting productive infections.
Immune response in leptospirosis to fibronectin/
fibrinogen-binding domain
The antigenicity of the binding domain in LigB appears to
account for a large part of the human immune response to LigB
(Figure 6), suggesting that LigB function is vulnerable to
disruption during infection. However, although an antibody
Figure 6. Leptospirosis patient antibodies recognize fibronec-
tin/fibrinogen-binding region of LigB. Immunoglobulins purified
from a pool of antisera of patients with acute infection (closed symbol)
and from a convalescent patient (open symbol) were titrated against
LigB proteins in an ELISA.
doi:10.1371/journal.pone.0016879.g006
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occur prior to the early activities proposed for the newly induced
leptospiral protein in a cutaneous wound. In addition, the binding
to repair proteins, such as fibroblastic fibronectin, type III
collagen, and elastin, following the initial hemostasis could occur
away from circulating antibodies raised either in a previous
infection or by vaccination. Therefore, the favored functional
niche of LigB may well be early in infection, particularly during
cutaneous entry. It is thus possible that whereas the conservation
of LigB in pathogenic strains [45] and the presence of LigB
antibodies in both the acute and convalescent phases of
leptospirosis support the feasibility of antibody-based diagnosis
[50], LigB vaccines may not be effective against the initial phase of
transmission mediated by the early activities of LigB. Once it
moves into the bloodstream to disseminate, the pathogen would
presumably become susceptible to antibodies. Immunization with
LigA protects hamsters from dying after non-cutaneous, direct
systemic infection via intraperitoneal inoculation [51]. However,
vaccination with a protein similar to LigB79-12 does not [51],
perhaps affirming the role of LigB early in the transmission of
leptospirosis.
Supporting Information
Figure S1 Lig expression in L. biflexa transformed with
lig genes from L. interrogans. LigA and LigB expression was
measured with an immunoblot of extracts from 1610
8 leptospires,
using a rabbit polyclonal antibody that recognizes both proteins.
Lane 1, Osmotic induction of Lig expression in L. interrogans
Copenhageni Fiocruz L1-130 grown overnight in EMJH with 120
mM NaCl. Lane 2, L. biflexa Patoc parental strain grown in
serum-free EMJH. Lane 3, L. biflexa ligA transformant. Lane 4,
L. biflexa ligB transformant. The positions of LigA (A) and LigB (B)
are marked; the smaller protein in the ligB transformant that also
occurs partially obscured and slightly larger than LigA in
L. interrogans is a breakdown product of LigB also detectable with
a LigB-specific antibody.
(PDF)
Table S1 Primers for cloning LigB proteins.
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